Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- S&P 500, Dow futures rise ahead of big bank results, CPI data
- Oil prices rise as Iran deploys new tactics to target tankers
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 58.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.13 | 52 Week High | $8.22 | |||
| Open | $58.13 | 52 Week Low | $3.07 | |||
| Day High | $58.13 | P/E | N/A | |||
| Day Low | $58.13 | EPS | $-1.30 | |||
| Volume | 3,502 | |||||
| (NASDAQ: MDGL) | Delayed: 452.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $452.12 | 52 Week High | $18.24 | |||
| Open | $452.12 | 52 Week Low | $6.60 | |||
| Day High | $452.12 | P/E | N/A | |||
| Day Low | $452.12 | EPS | $0.00 | |||
| Volume | 5 | |||||
